Futura Medical Share Discussion Threads

[mikethebike4] 10/4/2019 15:57

tiananmen that is exactly what FUM said about CSD500 the 'viagra' condom and look what happened to that - nothing, except revenue down from £360K in 2017 to ZERO in 2018 ! - at least in 2017 it covered Barders 1/4million+ remuneration ! From todays report :- CSD500 - condom containing the erectogenic Zanifil(R) gel In September 2018, Futura received approval for a two-year shelf life for CSD500 for its European contract condom manufacturer. This milestone provides the company with an opportunity to focus its R&D resource fully on the far greater potential of its leading asset, MED2005. As an innovative specialist R&D company, Futura does not have the marketing or regulatory medical device resource available to support the day-to-day requirements in a growing compliance-driven market and is in discussions with potential partners to assume these obligations. Futura expects to still benefit from the Intellectual Property of CSD500 through potential royalties, but the immediate potential for substantial royalties is low in the absence of a large global brand 'carrier' to take the product forward as previously advised. The Company will continue to explore national, multi-territory and regional agreements where the opportunities arise. The Company is expected to benefit from annual cost savings of approximately GBP400k in the event that it no longer maintains regulatory clearance itself for CSD500 as a medical device. - don't hold your breath !

[tiananmen] 10/4/2019 14:38

We were not expecting anything significant from today's announcement and that is what we got. We still have to wait until the Phase III results are finished until it gets approval, nothing has changed, the early signs is that this drug is going to make a substantial impact on the market.

[j777j] 10/4/2019 12:57

That is for the USAFirst one is for Europe and we are half way stage.15% royalties on $1.4 billion peak sales is $210,000,000 a year.That is 5 times current market cap annually.All to play for.

[5oletrader] 10/4/2019 12:30

They also said... "Planning for a SECOND, CONFIRMATORY Phase 3 study for MED2005 has been UNDERTAKEN.. ... THIS STUDY is expected to be informed by the FIRST Phase 3 and therefore START AFTER END of the FIRST PHASE 3 STUDY... The way I see it - 'POTENTIAL' and 'EXECUTION' are two totally different beasts. Only time will tell. ATB

[j777j] 10/4/2019 11:26

Meanwhile back in the real world,it is all systems go for a product that could generate 15% royalties on peak sales of $1.4 billion pa."Futura medical confirmed it will deliver the results from its phase III trial for a fast-acting gel for erectile dysfunction (ED) by the end of the year, a milestone which expects to be a "major value inflection point". The first of two studies of MED2005 got underway in October treating 1,000 men at 60 centres across Europe. Headline data should be released towards the back-end of 2019, the company said."

[slicethepie] 10/4/2019 09:28

It's incompetence, barder background is insurance, he has no experience exploiting technology, if the board was credible it would have replaced him but they are his appointees.

[lbo] 10/4/2019 09:26

Futura Medical plc James Barder, Chief Executive mail to: [e-mail]

[savagedstock] 10/4/2019 08:47

there's 12 months of cash left....that's it. there is nothing in the statement that shows any material progress in the last 12 months, a research paper and chinwagging with a few 'luminaries' hardly counts as progress.... After the recent ramping, expect another cash call in Q4 at about 4p...

[slicethepie] 10/4/2019 08:25

You have to own this despite barder, he could turn gold into lead, there is real value here BUT he is so out of his depth that we could end up with nothing!

[j777j] 09/4/2019 12:14

Pre results shake out of weak holders.Happens every time.15% royalty on projected $1.4 billion peak sales is $210 million pa.In it to win it.

[wantage] 09/4/2019 10:17

presumably usual suspects selling

[sibeks] 09/4/2019 08:13

o dear maybe 10p at the close

[j777j] 08/4/2019 09:43

Maybe the close then?Amazing here is a co with a potential blockbuster drug which could see peak sales of $1.4 billion a year with a market cap at what would be a couple of months royalties!You don't see that very often.

[sibeks] 07/4/2019 18:21

20p tomorrow on the open.

[penciles2] 03/4/2019 19:04

Firming up

[markymanc] 02/4/2019 12:17

Nice to see some movement. Certainly moves quickly!

[j777j] 02/4/2019 11:47

I guess hence the further two top 5 European pharmas co's signing up for Tpr100 has been forecast for this year by the house broker Singer.

[rrr] 02/4/2019 10:37

Thanks re TPR timescale J777J.

[j777j] 02/4/2019 08:17

Tpr was submitted last July and takes around a year,So getting close.Hopefully plenty of news in next week or so.

[mikethebike4] 02/4/2019 08:14

steady buying today - prelims. on the 10th ? - might get some 'deal' news

[rrr] 29/3/2019 09:32

The only thing I can find is that TPR100 response from UK regulators is expected in 2019, is there any other information as to more precisely when it may be?

[rrr] 26/3/2019 17:10

And of course the results and webcast on 10/4 may shed some more light on things.